Back to
Benjamin Edwards Inc.
CRSP
Showing 8 of 30 quarters
Position history for
Benjamin Edwards Inc.'s holdings in CRISPR Therapeutics AG
Yes. Benjamin Edwards holds 54,488 shares of CRSP (CRISPR Therapeutics), worth $3M, as of its Q2 2026 13F filing. It reduced the position by 1,018 shares (-1.8%) from Q1 2026. Benjamin Edwards has held CRSP in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$3M
Current Shares
54,488
Total Value Change
+$1.4M
Total Shares Change
+21,785
Quarter-by-Quarter History